Blood safety markers in Dutch donors after relaxation of deferral for men who have sex with men: re‐emergence of syphilis and HIV pre‐exposure prophylaxis use

• Published in: Transfusion (Philadelphia, Pa.) Vol. 64; no. 9; pp. 1732 - 1742
• Main Authors: Quee, Franke A., Slot, Ed, Leeuwen, Ingeborg, Brands, Ralph, Franssen, Eric J. F., Hogema, Boris M., Zaaijer, Hans L., Laar, Thijs J. W.
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.09.2024; Wiley Subscription Services, Inc
• Subjects: Adult; Blood; Blood & organ donations; Blood Donors; Blood Safety; Criteria; Disease prevention; Donor Selection; Drug development; Female; HIV; HIV Infections - epidemiology; HIV Infections - prevention & control; Homosexuality, Male; Human immunodeficiency virus; Humans; Incidence; Male; Men; Middle Aged; Netherlands - epidemiology; Pre-Exposure Prophylaxis; Prophylaxis; Risk factors; Safety; Sex; Sexually transmitted diseases; STD; Syphilis; Syphilis - epidemiology; Syphilis - prevention & control; Transfusion; Urban areas; Young Adult; Netherlands
• ISSN: 0041-1132; 1537-2995; 1537-2995
• DOI: 10.1111/trf.17941

Background Less discriminatory donor selection policies for men who have sex with men (MSM) may impact transfusion safety in terms of higher residual risks for known transfusion‐transmitted infections (TTIs), increased vulnerability toward new TTIs that are also transmitted via sex, and HIV infections masked by pre‐exposure prophylaxis (PrEP). Study Design and Methods TTI trends in Dutch donors were studied over a 13‐year period (2011–2023), characterized by successive relaxations of MSM deferral criteria. Structured posttest counseling was performed to determine risk factors in TTI‐positive donors. PrEP drug levels were measured in 9977 donations from male donors living in urban areas and in 67 donors with active or resolved syphilis. Results HIV incidence (from 5.8 to 1.5 per 1,000,000 donor years (DY)) and HBV incidence (from 12.4 to 4.5 per 1,000,000 DY) in Dutch donors decreased with less stringent MSM deferral criteria, while syphilis prevalence (from 26.4 to 44.1 per 100,000 new donors) and syphilis incidence (from 18.3 to 46.3 per 1,000,000 DY) increased over time. The proportion of MSM‐related syphilis rose from 2% to 32% in new donors and from 12% to 27% in repeat donors. PrEP was detected in 2 of 9977 (0.02%) donations from male donors living in urban areas, and in 1 of 39 (2.6%) male donors with syphilis. Discussion To date, phasing out donor deferral for MSM had no significant impact on transfusion safety in the Netherlands. However, rising syphilis rates and (recent) PrEP use in the blood donor population, albeit rare, suggest an influx of donors with higher sexual risk profiles and requires intensified TTI surveillance in donors.